Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Kaeren,
GM disagrees with a takeover, decides to bow out and Big Pharma places its pawn as CEO
Realistic?
Sorry if I misled , I assumed we could attend , in which case my flight would be booked in a nano second.
I am never keen on somebody leaving staying in situ. It is weird to announce retiring and the new CEO doesn't take over for a few months. Do we know if he is in situ. If I was taking over then I wouldn't want ANY decisions being taken which could impact my ability to perform in a certain manner, be it acquisitions, R & D , senior hires , contracts etc. Something strange afoot !
My question is short but would say a lot.
Have the it-is Directors achieved/getting near to their year end bonus target?
Guys,
I desperately don’t want to sound patronising here but RI are being played like a bloody Stradivarius
For those not properly researched here, think about it; they have released a RNS today confirming an investor talk on the 17th when they are being open to all Q & A about the business.
AND that RNS warrants a 10p mark down and another £ 7m off the companies’ value, does it??
No, it does not, this is a deliberate move to try and shake out a few retail. Maybe WQ planting a short for a final shakedown before closing or some two-bit fund like Invest Securities selling a few to buy back to squeeze a few quid out of it who knows….
What I do know is this.
This is a business with a leading World Class Bioinformatics section, I will say that again a “Leading worldwide Bioinformatics section” the business sis worth a dam sight ore than £ 223m
Now if anyone is daft enough to want to sell into that and capitulate then go for it, close your positions off and move on that my best advise.
Meanwhile, I’m continuing to add and you for any doubters just make of that what you will
Good Luck what ever your call
Pork’s
There's no reason not to have attendees at the AGM, there are no covid restrictions. Besides they could stick a couple of Q32s in the lobby and test attendees, the least they could do ;-)
mgmidget, agreed, ref not wish to compete with customers, and that had crossed my mind. Let's hope we have sufficient customers to make the trade off worth it and our estimation of 20-30% is indeed correct [there's another question]. I think our main concern is that GM may have gone off the boil at this critical stage in the company's history, let's hope not. With little news emerging doubts can enter one's mind. I have too much invested to run my faith on empty. Let's hope they drop some positive news before the meeting as some have been anticipating/speculating.
I too [Kaeren] am a little curious as to why they would hold this so soon before the AGM. Did someone say there is a possibility of attending in person? I doubt it for either meeting, but please correct me if I'm wrong - I'll be down there like a shot if it is possible.
@Hillseaker I think the reason they may not have gone into providing a travel test service is that would put them in competition with many of their customers. I reckon they are sticking to the knitting. Re the current share price I have no idea as to why it has dropped other than every time an RNS comes out the market makers seem to make it drop and without specific news doubt always seems to be cast. I am remaining very settled with my savings in this as all will come out in due course. Also happy about a marketing orientated CEO coming soon.
Correctio: Knight not night, of course - the K makes a big difference.
@Hopeful32 you wrote:
"My concern is that private travel sales are not great with other companies such as Randox capturing market share."
They would have to be extraordinarily inept to have declining sales with a booming travel market. The only way this would be possible is to loose existing customers to more competitive (i.e cheaper) competitors and not be gaining any new customers. This is possible but, I believe, unlikely, due to the information out there. There is no evidence (so far) that any of the labs such as Boots, Wren or Katalsyst have dropped us as their supplier.
However, I do think we have missed a trick and it may possibly be getting too late now, if we don't act quickly, to make the most of the potential gains. There seems to be an incredible amount of money to be made in the short to medium term, with huge mark-ups, through lab work. Why we did not purchase or lease one of the mothballed, high-throughput lighthouse labs is beyond me. This should have been the next logical step in vertical integration. It is clear that many of the smaller labs cannot keep up with demand and are providing a very shoddy service, leaving the likes of Randox to clear up, as you say. [Even thought their reviews are not great either by all accounts.]
We should act as a night in shining armer to clear the backlog by providing an efficient, quality, well-priced gold standard serve. If successful, the lab could then have continued to provide testing services using our huge portfolio of 550 plus products. Someone seems to have lost there and agility, foresight and hunger for money making activity.
That would have been my question (to add to all those already provided by other bb members) - the lab space seems an area where we could develop or acquire (M&A). Why have we done nothing?
We have 90m in the bank , use a couple of million to buy a lab, staff it properly and put some full spreads in the news papers and get an agreement with Jet 2 or Ryanair to get our name out - advertise it at a couple of quid cheaper than Randox.
There's literally hundreds of thousands of additional sales to be made. Even if it's just for a year or two. Please show us you are doing something.
They have recognised the sp is/has tanked and are trying to redress the situation. Once the DHSC issue is resolved will they consider a share buyback? A bit too late to bail out for most investors myself included so need to start plotting a way forward. Lots of different theories on here let's see how it pans out. My concern is that private travel sales are not great with other companies such as randox capturing market share. GLA long term holders let's hope our conviction/faith gets repaid